Wei Su

2.1k total citations · 1 hit paper
64 papers, 1.3k citations indexed

About

Wei Su is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Wei Su has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Wei Su's work include Ferroptosis and cancer prognosis (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wei Su is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Chronic Kidney Disease and Diabetes (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Wei Su collaborates with scholars based in China, United States and France. Wei Su's co-authors include Ying‐Yong Zhao, Dan‐Qian Chen, Nosratola D. Vaziri, Hua Chen, Xiao-Yong Yu, Hua Miao, Xu Bai, Yan Guo, Shixing Ma and Lin Chen and has published in prestigious journals such as Free Radical Biology and Medicine, British Journal of Pharmacology and Frontiers in Immunology.

In The Last Decade

Wei Su

58 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Lactobacillus johnsonii to reverse chronic kidney disease

2024 61 citations Hua Miao, Fei Liu et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Su China	22	446	290	208	170	131	64	1.3k
Hong Jin China	20	459 1.0×	151 0.5×	103 0.5×	155 0.9×	199 1.5×	52	1.6k
Lihua Wang China	19	233 0.5×	269 0.9×	176 0.8×	88 0.5×	129 1.0×	70	983
Brian B. Ratliff United States	23	794 1.8×	465 1.6×	211 1.0×	185 1.1×	259 2.0×	43	2.0k
Haijiao Jin China	11	652 1.5×	384 1.3×	182 0.9×	332 2.0×	71 0.5×	37	1.3k
Stéphane Poitevin France	16	505 1.1×	479 1.7×	78 0.4×	85 0.5×	224 1.7×	25	1.3k
Shrey Kohli Germany	20	567 1.3×	185 0.6×	74 0.4×	183 1.1×	99 0.8×	42	1.4k
Xi Qiao China	18	354 0.8×	321 1.1×	111 0.5×	86 0.5×	107 0.8×	47	1.0k
Jianxiao Shen China	11	707 1.6×	382 1.3×	138 0.7×	335 2.0×	77 0.6×	27	1.2k
Li Qin China	25	509 1.1×	188 0.6×	114 0.5×	538 3.2×	241 1.8×	88	1.9k
Jinbo Hu China	24	287 0.6×	209 0.7×	100 0.5×	236 1.4×	216 1.6×	102	1.6k

Countries citing papers authored by Wei Su

Since Specialization

Citations

This map shows the geographic impact of Wei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Su more than expected).

Fields of papers citing papers by Wei Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Su. The network helps show where Wei Su may publish in the future.

Co-authorship network of co-authors of Wei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Su. A scholar is included among the top collaborators of Wei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Su. Wei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Wei, et al.. (2025). Study on the effect of hydrophilic modification of polydopamine and polyacrylamide on coal characteristics and dust control. Chemical Engineering Science. 314. 121841–121841. 2 indexed citations

Gao, Yufeng, et al.. (2025). Analysis of clinical and psychological characteristics of 225 children with autism spectrum disorder based on the C-PEP-3 scale. World Journal of Psychiatry. 15(3). 101101–101101. 1 indexed citations

Miao, Hua, Fei Liu, Yanni Wang, et al.. (2024). Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduction and Targeted Therapy. 9(1). 195–195. 61 indexed citations breakdown →

Su, Wei, et al.. (2024). MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1. Cell Death Discovery. 10(1). 363–363. 9 indexed citations

Cui, Ying, Zhenzhen Hou, Mengge Zhang, et al.. (2024). CHK1 controls zygote pronuclear envelope breakdown by regulating F-actin through interacting with MICAL3. EMBO Reports. 25(11). 4876–4897.

Li, Yuting, Qinghua Wang, Xiaopan Gao, et al.. (2024). Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities. Frontiers in Immunology. 15. 1423796–1423796.

Su, Wei, et al.. (2023). Circulating sNinj1 as a novel predictor of prognosis and severity in hepatocellular carcinoma. Clinica Chimica Acta. 550. 117581–117581. 2 indexed citations

Wu, Haibin, Xiaojing Wang, & Wei Su. (2023). Synthesis of lithium slag-based ANA zeolite and molecular dynamics study of carbon dioxide adsorption performance. Vibroengineering PROCEDIA. 51. 114–120. 1 indexed citations

Miao, Hua, Yanni Wang, Xiao‐Yong Yu, et al.. (2023). Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan‐produced indole metabolites. British Journal of Pharmacology. 181(1). 162–179. 82 indexed citations

10.

Liao, Jun, Yuhan Sun, Yi Li, et al.. (2023). Advanced nano drug delivery systems for neuroprotection against ischemic stroke. Chinese Chemical Letters. 35(2). 109149–109149. 30 indexed citations

11.

Zhou, Yang, Chengjian Ji, Xiaohan Ren, et al.. (2023). OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis. iScience. 26(11). 108148–108148. 12 indexed citations

12.

Yue, S., et al.. (2023). Saffron reduces the liver fibrosis in mice by inhibiting the JAK/STAT3 pathway. Acta Cirúrgica Brasileira. 38. e385823–e385823. 6 indexed citations

13.

Ding, Ran, et al.. (2023). Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer. Frontiers in Oncology. 13. 1108472–1108472. 7 indexed citations

14.

Yang, Shiyu, Heming Chen, Wei Su, et al.. (2023). Protective effects of Salvianic acid A against multiple-organ ischemia-reperfusion injury: a review. Frontiers in Pharmacology. 14. 1297124–1297124. 10 indexed citations

15.

Su, Wei, Yang Tai, Yanting Ye, et al.. (2020). Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats. World Journal of Gastroenterology. 26(28). 4094–4107. 26 indexed citations

16.

Feng, Ya‐Long, Hua Chen, Dan‐Qian Chen, et al.. (2019). Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(9). 2317–2332. 46 indexed citations

17.

Luo, Yongjiang, et al.. (2015). Detection Of Multilayer Cavities By Employing RC-DTH Air Hammer System And Cavity Auto Scanning Laser System. Archives of Mining Sciences. 60(4). 1041–1052.

18.

Xu, Danling, Cheng Fang, Wei Su, et al.. (2011). Protective Effect of Tongxinluo on Oxidative Injury Induced by Angiotensin II in Rats. Zhōnghuá mínguó xīnzàngxué huì zázhì. 27(3). 189–196. 3 indexed citations

19.

Su, Wei, De‐Zai Dai, Haoran Liu, Tao Na, & Yin Dai. (2007). UPREGULATED ENDOTHELIN SYSTEM IN DIABETIC VASCULAR DYSFUNCTION AND EARLY RETINOPATHY IS REVERSED BY CPU0213 AND TOTAL TRITERPENE ACIDS FROM FRUCTUS CORNI. Clinical and Experimental Pharmacology and Physiology. 34(12). 1228–1233. 41 indexed citations

20.

Zhang, Tiantai, Bing Cui, De‐Zai Dai, & Wei Su. (2005). CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway1. Acta Pharmacologica Sinica. 26(11). 1309–1316. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact